Reactivation of Multidrug-Resistant HSV-1 in a Post-Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing

Shuxuan Zheng, Lidewij L.W. Rümke, Bruno Tello Rubio, Malbert R.C. Rogers, Geerte L. Van Sluis, Jürgen H.E. Kuball, Annelies Riezebos-Brilman, Robert Jan Lebbink, Frans M. Verduyn Lunel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

54 Downloads (Pure)

Abstract

We present an immunocompromised patient with a multiresistant herpes simplex virus-1 reactivation with a rare mutation (A605V) in the viral DNA polymerase gene. Next-generation sequencing suggests the presence of multiple drug-resistant strains before treatment and altered ratios during treatment, affecting the clinical response to aciclovir and foscarnet.

Original languageEnglish
Article numberofae250
JournalOpen Forum Infectious Diseases
Volume11
Issue number5
DOIs
Publication statusPublished - 1 May 2024

Keywords

  • aciclovir
  • foscarnet
  • HSV-1
  • multidrug resistance
  • stem cell transplantation

Fingerprint

Dive into the research topics of 'Reactivation of Multidrug-Resistant HSV-1 in a Post-Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing'. Together they form a unique fingerprint.

Cite this